Good News! MOMED BIOTECH has been awarded the Top 30 Most Investment-Worthy Projects at the
Good Fortune in the Year of the Horse · Warm Congratulations
In January 2026, the 2025 Global Angel Investment Summit (GAIS) and the annual "Ge Chuang Hui" event grandly opened in Gedian Economic Development Zone, Ezhou, Hubei Province.MOMED BIOTECH was invited to participate. With its outstanding strength, the project stood out among many competitors and won the honorary trophy of Top 30 Most Investment-Worthy Projects!
In January 2026, the 2025 Global Angel Investment Summit (GAIS) and the "Ge Chuang Hui" Annual Meeting grandly opened in Gedian Economic Development Zone, Ezhou, Hubei Province. This grand industry event brought together more than 300 top domestic and foreign investment institutions and over 600 elites from the venture capital community. Under the theme "Innovation Without Borders, Gathering for Excellence", it focused on cutting-edge fields such as hard technology, artificial intelligence, and biomedicine, building a high-quality platform for the in-depth integration of capital and technological innovation.
Sun Bing, Secretary of the CPC Ezhou Municipal Committee, attended and delivered a speech. Li Hongbin, Second-Class Inspector of the Department of Human Resources and Social Security of Hubei Province, Lu Hui, Member of the Standing Committee of the CPC Ezhou Municipal Committee and Vice Mayor of Ezhou, and Qiu Jianming, Director of the Administrative Committee of Gedian Economic Development Zone, also attended the event.

At the summit, biomedicine, as one of the key sectors, gathered many high-quality projects dedicated to technological R&D and industrial implementation, with particularly fierce competition.MOMED BIOTECH was invited to attend the summit.
Its core project stood out in the intense competition of the biomedicine session, thanks to its technological innovation in AI-driven drug discovery, mature project layout, market-oriented development strategy, and robust technical strength.
Its breakthrough progress in protein functional mechanism analysis and AI-enabled drug discovery gained high recognition from investment institutions and expert judges on site.


Being invited to the summit and awarded this honor is a full recognition of MOMED BIOTECH’s technological strength and development potential in the biomedicine industry, and a strong testament to the company’s commitment to scientific and technological innovation.
All along, MOMED BIOTECH has been focusing on the core field of AI-driven drug discovery, adhering to technology-driven development, continuously increasing R&D investment, upgrading its proprietary technology platform, advancing core drug pipelines, and building strong corporate competitiveness.
Text and photo credits
1
Hubei Daily
2
Gedian National Development Zone
END
NEW YEAR -
Hot News
- 2024-10-31
- 2024-11-22
- 2025-01-16
-
2025-01-17
MoMed Biotech's Moments on CCTV! Catch the Wonderful Highlights in Advance!
